Medicare Procedure and Patient Information
2012 Medicare Procedure Volume
Volume of procedures performed by Dr. Robert Mark Richardson, MD, PhD for Medicare patients.
| doctor visit | 16 |
|---|
Dr. Robert Mark Richardson, MD, PhD is a neurosurgeon in Boston, MA specializing in neurosurgery and pediatric neurosurgery. He graduated from Virginia Commonwealth University (VCU) School of Medicine. Dr. Robert Mark Richardson, MD, PhD is affiliated with Massachusetts General Hospital and Mass General Neurosurgery.
Deep Brain Stimulation (DBS)
Deep brain stimulation (DBS) is a procedure performed to help treat neurological conditions such as Parkinson's disease and epilepsy. Electrode leads are surgically implanted in the brain and connected to a device, called a neurostimulator (deep brain stimulator), that is placed underneath the skin (subcutaneously). The deep brain stimulator can send electrical signals through the electrodes to the brain to restore normal rhythms, or it can block electrical signals in specific areas of the brain to restore functioning. Although not a cure, DBS can treat symptoms of movement disorders such as pain and tremor when medication fails to work.
DBS surgery may be completed in one operating session, but it is more commonly performed in two parts. In the first stage of the procedure, the surgeon will map targets in the brain using CT or MRI imaging to determine where to place the electrodes. Then, by drilling holes into the skull, the surgeon will place the electrodes into specific areas in the brain. The holes will be closed, and patients will require 1-2 days to recover in the hospital. After about two weeks, patients will undergo another surgery to have the deep brain stimulator implanted. The stimulator is usually placed under the skin around the collarbone, chest, or abdomen, and it will be connected to the DBS electrodes through a subcutaneous wire. No component of the DBS system will be visible from outside. Following stimulator implantation, patients may need to recover in the hospital for 1-2 days.
Within 2-4 weeks of the operation, doctors will program the stimulator using a wireless device. Patients will work with their doctor to determine the most effective settings for the stimulator during follow-up visits. Patients will be given a handheld device so that they can turn the stimulator on or off and adjust its settings themselves. The stimulator may have a rechargeable battery, in which case patients will be given a charging unit. Stimulator batteries generally need to be replaced in 3-5 years.
Obsessive-Compulsive Disorder (OCD)
Obsessive-compulsive disorder, commonly referred to as "OCD," is a disorder characterized by patterns of unwelcome thoughts, ideas, or feelings (known as "obsessions") that may cause people to perform repetitive actions. For example, people with OCD may feel compelled to repeatedly wash their hands or to clean or to check on doors to confirm that they are indeed locked. These repetitive behaviors are often fueled by fears or strong beliefs about personal control and potential dangers. The compulsive thoughts and ritualistic behaviors associated with OCD can interfere with daily life and cause severe distress.
OCD frequently revolves around themes such as the fear of contracting germs or the fear of death. Common obsessions include:
These obsessions and compulsions often contribute to anxiety, depression, and recurring emotions of fear and disgust. People with OCD cannot "turn off" their patterns of thought or behavior, and thus must continually grapple with urges to behave or think in a certain way, as well as the emotions associated with these urges. Some OCD patients describe their entire life as revolving around their obsessions and compulsions and this can result in their missing out on important school and social activities, travel, and family time. The impact of OCD is extensive and can even make daily activities like drinking, reading, sleeping, and eating extremely difficult.
The obsessions manifest in compulsive behaviors that can have negative implications on one's life. Some examples of compulsive behaviors include, among others:
Obsessive-compulsive disorder affects adults, adolescents, and children. OCD has been observed in children as young as five or six years of age, usually through sensitivity issues, obsessions about dirt or germs, or repeated doubts. The cause of obsessive-compulsive disorder is unknown. However, a person's likelihood of developing the condition may be increased by a number of variables such as family history, stressful life events, and pre-existing mental health disorders.
OCD is diagnosed based on a patients' reported symptoms. For example, a pediatrician or child psychiatrist may ask children (or their parents) how often they wash their hands or experience behavioral urges. Psychiatrists will evaluate patients for other symptoms and may instruct patients to describe their mental processes, thought patterns, and previous traumatic experiences.
While there is no cure for OCD, treatment can greatly improve patients' functioning in daily routines and activities. A common treatment for OCD is cognitive behavioral therapy (CBT), which helps patients identify negative patterns of thought and behavior and learn how to adjust them. Aversion therapy may also help those who have a fear of germs or contamination by forcing them to confront their fear and slowly overcome it. Many patients also benefit from counseling to address the anxiety, stress, and trauma that may accompany OCD. Other treatments for OCD include oral medications such as selective serotonin reuptake inhibitors (SSRIs, which are antidepressants) to normalize levels of a brain chemical called serotonin, which may improve OCD symptoms. Medications such as fluoxetine (Prozac) and sertraline (Zoloft) can help alleviate OCD-related behavioral urges, anxiety, and depression. Many OCD patients also find OCD support groups helpful to learn new coping strategies, to socialize, and to verbalize their emotions and experiences.
It is important to note that while OCD is a common mental health disorder, it is not a personality trait. The term "OCD" is sometimes used to informally describe someone having a tendency towards organization or orderliness. This usage is pervasive but inappropriate - OCD is a severe, life-altering condition. Some people with OCD who successfully manage their symptoms find that they may benefit from other traits that may be associated with OCD, such as high attention to detail and precision.
Click on any procedure below to see further details on volume and pricing among Medicare patients.
In 2023, Dr. Robert Mark Richardson, MD, PhD performed more cranial neurostimulator implantation, and neurostimulator replacement procedures for Medicare patients than 95% of providers in related specialties within Massachusetts.
Volume of procedures performed by Dr. Robert Mark Richardson, MD, PhD for Medicare patients.
| doctor visit | 16 |
|---|
The top procedures that Dr. Robert Mark Richardson, MD, PhD treated as a neurosurgeon in Boston, MA during 2013 were neurostimulator replacement and implant surgery.
Volume of procedures performed by Dr. Robert Mark Richardson, MD, PhD for Medicare patients.
| doctor visit | 34 |
|---|---|
| implant surgery | 25 |
| neurostimulator replacement | 25 |
Information about Medicare patients treated by Dr. Robert Mark Richardson, MD, PhD.
| Male | 45 |
|---|---|
| Female | 30 |
| From 65 to 74 | 25 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 38 |
| Hypertension | 51 |
|---|---|
| High Cholesterol | 47 |
| Stroke | 16 |
| Ischemic Heart Disease | 28 |
| Depression | 31 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 20 |
| Dementia | 0 |
| Cancer | 0 |
The top procedures that Dr. Robert Mark Richardson, MD, PhD treated as a neurosurgeon in Boston, MA during 2014 were neurostimulator replacement and implant surgery.
Volume of procedures performed by Dr. Robert Mark Richardson, MD, PhD for Medicare patients.
| doctor visit | 45 |
|---|---|
| implant surgery | 30 |
| neurostimulator replacement | 30 |
Information about Medicare patients treated by Dr. Robert Mark Richardson, MD, PhD.
| Male | 39 |
|---|---|
| Female | 33 |
| From 65 to 74 | 25 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 36 |
| Hypertension | 50 |
|---|---|
| High Cholesterol | 38 |
| Stroke | 0 |
| Ischemic Heart Disease | 32 |
| Depression | 44 |
| Chronic Kidney Disease | 24 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 26 |
| Dementia | 17 |
| Cancer | 0 |
The top procedures that Dr. Robert Mark Richardson, MD, PhD treated as a neurosurgeon in Boston, MA during 2015 were neurostimulator replacement and implant surgery.
Volume of procedures performed by Dr. Robert Mark Richardson, MD, PhD for Medicare patients.
| doctor visit | 34 |
|---|---|
| implant surgery | 30 |
| neurostimulator replacement | 30 |
Information about Medicare patients treated by Dr. Robert Mark Richardson, MD, PhD.
| Male | 76 |
|---|---|
| Female | 74 |
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 80 |
| Hypertension | 44 |
|---|---|
| High Cholesterol | 41 |
| Stroke | 0 |
| Ischemic Heart Disease | 25 |
| Depression | 51 |
| Chronic Kidney Disease | 25 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 17 |
| Dementia | 20 |
| Cancer | 0 |
The top procedures that Dr. Robert Mark Richardson, MD, PhD treated as a neurosurgeon in Boston, MA during 2016 were neurostimulator replacement, implant surgery, neurostimulator lead placement and cranial surgery.
Volume of procedures performed by Dr. Robert Mark Richardson, MD, PhD for Medicare patients.
| cranial surgery | 12 |
|---|---|
| doctor visit | 28 |
| implant surgery | 40 |
| neurostimulator lead placement | 12 |
| neurostimulator replacement | 40 |
Information about Medicare patients treated by Dr. Robert Mark Richardson, MD, PhD.
| Male | 46 |
|---|---|
| Female | 33 |
| From 65 to 74 | 31 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 35 |
| Hypertension | 49 |
|---|---|
| High Cholesterol | 46 |
| Stroke | 0 |
| Ischemic Heart Disease | 22 |
| Depression | 44 |
| Chronic Kidney Disease | 0 |
| Asthma | 16 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 16 |
| Dementia | 22 |
| Cancer | 0 |
The top procedures that Dr. Robert Mark Richardson, MD, PhD treated as a neurosurgeon in Boston, MA during 2017 were neurostimulator replacement, implant surgery, neurostimulator lead placement and cranial surgery.
Volume of procedures performed by Dr. Robert Mark Richardson, MD, PhD for Medicare patients.
| cranial surgery | 11 |
|---|---|
| doctor visit | 16 |
| implant surgery | 37 |
| neurostimulator lead placement | 11 |
| neurostimulator replacement | 37 |
Information about Medicare patients treated by Dr. Robert Mark Richardson, MD, PhD.
| Male | 37 |
|---|---|
| Female | 29 |
| From 65 to 74 | 26 |
|---|---|
| From 75 to 84 | 15 |
| 85 and over | 0 |
| Less than 65 | 25 |
| Hypertension | 52 |
|---|---|
| High Cholesterol | 55 |
| Stroke | 0 |
| Ischemic Heart Disease | 32 |
| Depression | 48 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 21 |
| Cancer | 17 |
The top procedures that Dr. Robert Mark Richardson, MD, PhD treated as a neurosurgeon in Boston, MA during 2018 were neurostimulator replacement, implant surgery, neurostimulator lead placement and cranial surgery.
Volume of procedures performed by Dr. Robert Mark Richardson, MD, PhD for Medicare patients.
| cranial surgery | 17 |
|---|---|
| implant surgery | 41 |
| neurostimulator lead placement | 17 |
| neurostimulator replacement | 41 |
Information about Medicare patients treated by Dr. Robert Mark Richardson, MD, PhD.
| Male | 41 |
|---|---|
| Female | 23 |
| From 65 to 74 | 39 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 66 |
|---|---|
| High Cholesterol | 58 |
| Stroke | 0 |
| Ischemic Heart Disease | 27 |
| Depression | 47 |
| Chronic Kidney Disease | 25 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 20 |
| Dementia | 31 |
| Cancer | 0 |
The top procedures that Dr. Robert Mark Richardson, MD, PhD treated as a neurosurgeon in Boston, MA during 2019 were neurostimulator replacement and implant surgery.
Volume of procedures performed by Dr. Robert Mark Richardson, MD, PhD for Medicare patients.
| implant surgery | 18 |
|---|---|
| neurostimulator replacement | 18 |
Information about Medicare patients treated by Dr. Robert Mark Richardson, MD, PhD.
| Male | 25 |
|---|---|
| Female | 12 |
| From 65 to 74 | 20 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 57 |
|---|---|
| High Cholesterol | 57 |
| Stroke | 0 |
| Ischemic Heart Disease | 41 |
| Depression | 49 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
| Hypertension | 0 |
|---|---|
| High Cholesterol | 0 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 58 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
| Hypertension | 0 |
|---|---|
| High Cholesterol | 0 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 68 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
The top procedures that Dr. Robert Mark Richardson, MD, PhD treated as a neurosurgeon in Boston, MA during 2022 were neurostimulator replacement and implant surgery.
Volume of procedures performed by Dr. Robert Mark Richardson, MD, PhD for Medicare patients.
| implant surgery | 13 |
|---|---|
| neurostimulator replacement | 13 |
Information about Medicare patients treated by Dr. Robert Mark Richardson, MD, PhD.
| Male | 17 |
|---|---|
| Female | 15 |
| From 65 to 74 | 16 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 34 |
|---|---|
| High Cholesterol | 53 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 59 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Robert Mark Richardson, MD, PhD for Medicare patients.
The highest averages for the top procedures that Dr. Robert Mark Richardson, MD, PhD treated as a neurosurgeon in Boston, MA were neurostimulator replacement, implant surgery, neurostimulator lead placement and cranial surgery.
| cranial surgery | 13 |
|---|---|
| doctor visit | 28 |
| implant surgery | 29 |
| neurostimulator lead placement | 13 |
| neurostimulator replacement | 29 |
Information about Medicare patients treated by Dr. Robert Mark Richardson, MD, PhD.
| Male | 29 |
|---|---|
| Female | 22 |
| 75 to 84 | 1 |
|---|---|
| 85 and over | 0 |
| Less than 65 | 19 |
| 65 to 74 | 16 |
The highest averages of the most common conditions of Medicare patients that Dr. Robert Mark Richardson, MD, PhD treated were depression, hypertension, high cholesterol and ischemic heart disease.
| Hypertension | 36 |
|---|---|
| High Cholesterol | 35 |
| Stroke | 1 |
| Ischemic Heart Disease | 18 |
| Depression | 45 |
| Chronic Kidney Disease | 6 |
| Asthma | 1 |
| Osteoporosis | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 9 |
| Atrial Fibrillation | 0 |
| Dementia | 10 |
| Cancer | 1 |
Dr. Robert Mark Richardson, MD, PhD graduated from Virginia Commonwealth University (VCU) School of Medicine. He completed residency at University of California, San Francisco (UCSF) Affiliated Hospitals. He is certified by the Neurological Surgery, American Board of Neurological Surgery and has a state license in Massachusetts.
Medical School: Virginia Commonwealth University (VCU) School of Medicine
Residency: University of California, San Francisco (UCSF) Affiliated Hospitals
Board Certification: Neurological Surgery, American Board of Neurological Surgery
Licensed In: Massachusetts
Dr. Robert Mark Richardson, MD, PhD is associated with these hospitals and organizations:
Dr. Robert Mark Richardson, MD, PhD appears to accept the following insurance providers: Harvard Pilgrim Health Care, MultiPlan, Tufts Health Plan, United Healthcare, Aetna, TRICARE, Medicare, Medicaid, Humana, Coventry, Cigna, Blue California, Beech Street, WellPoint, Medicare ACO, WellSense, Senior Whole Health, Fallon Health, Commonwealth Care Alliance, Blue Cross Blue Shield Medicare, Maine Community Health Options, Mass General Brigham Health Plan, MassHealth and WellSense NH.
According to our sources, Dr. Robert Mark Richardson, MD, PhD accepts the following insurance providers:
Dr. Robert Mark Richardson, MD, PhD has an exceptional overall rating with an average of 5.0 out of 5 stars based on 17 ratings. We collect ratings and reviews of Dr. Robert Mark Richardson, MD, PhD from all over the web to help you find the right in Boston, MA.
These charts describe general payments received by Dr. Robert Mark Richardson, MD, PhD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Medtronic USA, Inc. |
$39,060
ACTIVA $31,195 |
Deep Brain Neurostimulation $1,361 |
RECLAIM $1,040 |
Deep Brain Stimulation - ST $33 |
$5,431 |
|
|---|---|---|---|---|---|---|
| NeuroPace, Inc. |
$28,332
RNS Neurostimulator Kit $20,242 |
RNS System $7,997 |
RNSSystem $92 |
|||
| Zimmer Biomet Holdings, Inc. |
$13,087
ROSA $11,576 |
ROSA Brain $1,298 |
ROI A $137 |
ROSA CMFT $76 |
||
| ClearPoint Neuro, Inc. |
$11,186
CLEARPOINT $8,481 |
ClearPoint Neuro Workstation $1,810 |
ClearPoint System $896 |
|||
| Boston Scientific Corporation |
$6,378
GENERAL DBS $4,138 |
VERCISE $1,234 |
GENERAL THERAPIES $908 |
GENERAL - DBS $98 |
||
| Other |
$13,864
Kick, Airo, Curve, Buzz, Node, Exact Trac, Novalis, TramaCad, Elements $2,211 |
NeuroBlate $1,145 |
DBS Accessories $667 |
ClearPoint System $243 |
Infinity DBS Pulse Generators $177 |
Other $9,421 |
| Consulting Fee | $52,140 |
|---|---|
| Travel and Lodging | $27,716 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,820 |
| Food and Beverage | $11,032 |
| Grant | $1,200 |
Dr. Robert Mark Richardson, MD, PhD has received 42 research payments totaling $130,528.
Dr. Robert Richardson is a specialist in pediatric neurosurgery. He works in Boston, MA. Clinical interests for Dr. Richardson include dystonia, parkinson's disease, and epilepsy. He is affiliated with Massachusetts General Hospital. After completing medical school at Virginia Commonwealth University (VCU) School of Medicine, he performed his residency at a hospital affiliated with the University of California, San Francisco (UCSF). His patients gave him an average rating of 5.0 stars (out of 5). He accepts Blue California, Coventry, and Viant, in addition to other insurance carriers.